Published in J Chromatogr B Biomed Sci Appl on June 09, 2000
Food protein-stabilized nanoemulsions as potential delivery systems for poorly water-soluble drugs: preparation, in vitro characterization, and pharmacokinetics in rats. Int J Nanomedicine (2011) 1.01
Development and Validation of RP-HPLC Method for Simultaneous Estimation of Atorvastatin Calcium and Fenofibrate in Tablet Dosage Forms. Indian J Pharm Sci (2010) 0.92
The role of lipid-based nano delivery systems on oral bioavailability enhancement of fenofibrate, a BCS II drug: comparison with fast-release formulations. J Nanobiotechnology (2014) 0.85
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review. Int J Nanomedicine (2006) 0.82
Biomolecular chemistry of isopropyl fibrates. J Pharm Sci (2012) 0.80
Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation. Int J Nanomedicine (2015) 0.77
Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate. Int J Nanomedicine (2016) 0.75
Development and validation of bioanalytical UHPLC-UV method for simultaneous analysis of unchanged fenofibrate and its metabolite fenofibric acid in rat plasma: Application to pharmacokinetics. Saudi Pharm J (2016) 0.75
Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med (2001) 3.98
Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr (1996) 3.27
Successful small bowel transplantation in an infant. Transplantation (1992) 1.69
CHARGE syndrome: report of 47 cases and review. Am J Med Genet (1998) 1.68
Risk analysis of leukaemia incidence among people living along the Techa River: a nested case-control study. J Radiol Prot (2006) 1.54
[Sudden crib death. Experience in a referral center 1986-1991]. Arch Fr Pediatr (1993) 1.53
Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporos Int (2009) 1.47
Exposure of red bone marrow to ionising radiation from natural and medical sources in France. J Radiol Prot (2001) 1.46
[Severe respiratory syncytial virus infections. Study of 87 infants hospitalized in an epidemic]. Arch Fr Pediatr (1989) 1.41
Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia. J Pediatr (1994) 1.39
Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines. J Med Chem (1999) 1.18
Clinical outcome and long-term management of 17 patients with propionic acidaemia. Eur J Pediatr (1996) 1.17
Induction of maturation in Xenopus laevis oocytes by a steroid linked to a polymer. Proc Natl Acad Sci U S A (1978) 1.10
Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol (1993) 1.09
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial. Blood (2001) 1.06
Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo. Oncogene (2010) 1.06
Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin Exp Immunol (2008) 1.01
Identification of a potential effector pathway for the trimeric Go protein associated with secretory granules. Go stimulates a granule-bound phosphatidylinositol 4-kinase by activating RhoA in chromaffin cells. J Biol Chem (1998) 1.00
Chernobyl, 10 years after: health consequences. Epidemiol Rev (1997) 1.00
Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties. J Control Release (2004) 0.99
Liposome surface charge influence on skin penetration behaviour. Int J Pharm (2011) 0.99
Fast method for the simultaneous quantification of toxic polyphenols applied to the selection of genotypes of yam bean (Pachyrhizus sp.) seeds. Talanta (2013) 0.98
Sodium alginate sponges with or without sodium hyaluronate: in vitro engineering of cartilage. J Biomed Mater Res (2001) 0.97
Subperiosteal subtemporal approach: technique and applications. Neurosurgery (1992) 0.96
[Cerebral anoxia in near-drowning of children. The prognostic value of EEG]. Neurophysiol Clin (1991) 0.95
Definition and estimation of lifetime detriment from radiation exposures: principles and methods. Health Phys (1992) 0.94
The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity. Eur J Biochem (1996) 0.92
Definitive cure of hyperammonemia by liver transplantation in urea cycle defects: report of three cases. Transplant Proc (1994) 0.92
Substitution of the insulin receptor transmembrane domain with that of glycophorin A inhibits insulin action. FASEB J (1999) 0.92
Dietary (n-3) and (n-6) polyunsaturated fatty acids rapidly modify fatty acid composition and insulin effects in rat adipocytes. J Nutr (1998) 0.91
Blind protected specimen brush and bronchoalveolar lavage in ventilated children. Crit Care Med (1999) 0.91
Skin penetration behaviour of liposomes as a function of their composition. Eur J Pharm Biopharm (2011) 0.90
Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. Eur J Biochem (1995) 0.90
Chromostatin receptors control calcium channel activity in adrenal chromaffin cells. J Biol Chem (1992) 0.90
Innovative high-performance liquid chromatography method development for the screening of 19 antimalarial drugs based on a generic approach, using design of experiments, independent component analysis and design space. J Chromatogr A (2011) 0.89
Possible involvement of phosphatidylinositol 3-kinase in regulated exocytosis: studies in chromaffin cells with inhibitor LY294002. J Neurochem (1998) 0.89
Intravenous nicardipine in hypertensive children. Eur J Pediatr (1993) 0.89
Small intestinal transplantation in a child using cyclosporine. Transplant Proc (1988) 0.89
Inhibition by transmembrane peptides of chimeric insulin receptors. Cell Mol Life Sci (2005) 0.89
External radiation exposure and mortality in a cohort of French nuclear workers. Occup Environ Med (2007) 0.88
Direct evidence for internalization of mitochondrial aspartate aminotransferase into mitoplasts. Biochemistry (1979) 0.88
Controlled release of drugs from multi-component biomaterials. Acta Biomater (2008) 0.87
Enantiomeric determination of amlodipine in human plasma by liquid chromatography coupled to tandem mass spectrometry. J Biochem Biophys Methods (2002) 0.86
A new validation approach applied to the GC determination of impurities in organic solvents. J Pharm Biomed Anal (2005) 0.86
Serious childhood angiomas: unsuccessful alpha-2b interferon treatment. A report of four cases. Br J Dermatol (1993) 0.86
The transfer of a LC-UV method for the determination of fenofibrate and fenofibric acid in Lidoses: use of total error as decision criterion. J Pharm Biomed Anal (2006) 0.86
Craniofacial anomalies and malformations in respiratory chain deficiency. Am J Med Genet (1996) 0.86
Impact of delayed repair and elective high-frequency oscillatory ventilation on survival of antenatally diagnosed congenital diaphragmatic hernia: first application of these strategies in the more "severe" subgroup of antenatally diagnosed newborns. Intensive Care Med (2000) 0.85
Three new cases of the Schinzel-Giedion syndrome and review of the literature. Am J Med Genet (1994) 0.85
Determination of six water-soluble vitamins in a pharmaceutical formulation by capillary electrophoresis. J Pharm Biomed Anal (1997) 0.84
Cancer mortality among French Atomic Energy Commission workers. Am J Ind Med (2004) 0.83
Development and validation of a liquid chromatographic method for the determination of amlodipine residues on manufacturing equipment surfaces. J Pharm Biomed Anal (2003) 0.83
The organotypic culture of HPV-transformed keratinocytes: an effective in vitro model for the development of new immunotherapeutic approaches for mucosal (pre)neoplastic lesions. Vaccine (2001) 0.83
Cartilage repair using new polysaccharidic biomaterials: macroscopic, histological and biochemical approaches in a rat model of cartilage defect. Osteoarthritis Cartilage (2003) 0.83
[Mid-term outcome of 2 cases with maple syrup urine disease: role of liver transplantation in the treatment]. Arch Pediatr (1994) 0.83
Assessment of high-frequency neonatal ventilator performances. Intensive Care Med (1997) 0.83
Nonbacterial purpura fulminans and severe autoimmune acquired protein S deficiency associated with human herpesvirus-6 active replication. Br J Dermatol (2009) 0.83
Method development strategies for the enantioseparation of drugs by capillary electrophoresis using cyclodextrins as chiral additives. Electrophoresis (1998) 0.82
Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin. Clin Appl Thromb Hemost (2009) 0.82
Quantitative analysis of N-acetylcysteine and its pharmacopeial impurities in a pharmaceutical formulation by liquid chromatography-UV detection-mass spectrometry. J Chromatogr A (2000) 0.82
Hyaluronate-alginate gel as a novel biomaterial: mechanical properties and formation mechanism. Biotechnol Bioeng (1999) 0.82
Strategies for the diagnosis and treatment of bacteraemia in children with central venous catheters: an analysis. J Hosp Infect (2004) 0.81
Continuous venovenous haemodiafiltration in the acute phase of neonatal maple syrup urine disease. J Inherit Metab Dis (1997) 0.81
Minimum effective dose of midazolam for sedation of mechanically ventilated neonates. J Clin Pharm Ther (2005) 0.81
Lipid composition in liver and brain of genetically obese (ob/ob), heterozygote (ob/+)and normal (+/+) mice. Biochim Biophys Acta (1982) 0.81
Selection and characterization of two specific monoclonal antibodies directed against the two variants of human herpesvirus-6. Res Virol (1999) 0.81
[Antenatal form of Bartter's syndrome]. Ann Pediatr (Paris) (1993) 0.81
Metal chelate affinity chromatography. I. Influence of various parameters on the retention of nucleotides and related compounds. J Chromatogr (1980) 0.81
Enantiomeric separations of drugs using mixtures of charged and neutral cyclodextrins. J Chromatogr A (2000) 0.81
Affinity partitioning of steroid-binding proteins. The use of polyethylene oxide-bound estradiol for purifying delta 5 goes to 4 3-oxosteroid isomerase. FEBS Lett (1976) 0.80
Cartilage repair: surgical techniques and tissue engineering using polysaccharide- and collagen-based biomaterials. Biorheology (2004) 0.80
Modifications of cellular lipids induce insulin resistance in cultured hepatoma cells. Biochim Biophys Acta (1987) 0.80
[Spinal lipoma associated with a neuromuscular hamartoma. Report of one case]. Ann Pathol (1991) 0.80
[Toxic epidermal necrolysis in children (Lyell's syndrome). Apropos of 18 cases]. Arch Fr Pediatr (1987) 0.80
Influence of lipid environment on insulin binding in cultured hepatoma cells. Biochim Biophys Acta (1987) 0.79
Antibacterial activity of secretolytin, a chromogranin B-derived peptide (614-626), is correlated with peptide structure. FEBS Lett (1996) 0.79
Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis. Antimicrob Agents Chemother (1995) 0.79
Congenital chylothorax: what is the best strategy? Arch Dis Child Fetal Neonatal Ed (2006) 0.79
[Kasabach-Merritt syndrome in children]. Ann Pediatr (Paris) (1992) 0.79
Validation of a liquid chromatographic-tandem mass spectrometric method for the determination of loperamide in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.79
Interleukin-32 expression is associated with a poorer prognosis in head and neck squamous cell carcinoma. Mol Carcinog (2013) 0.79
Liver transplantation: new indications in metabolic disorders? Transplant Proc (1994) 0.79
Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT. Leukemia (1999) 0.79
Amphiphilic derivatives of sodium alginate and hyaluronate for cartilage repair: rheological properties. J Biomed Mater Res (2001) 0.79
Tailored SWCNT functionalization optimized for compatibility with epoxy matrices. Nanotechnology (2012) 0.78
Intestinal transplantation in children: preliminary experience in Paris. JPEN J Parenter Enteral Nutr (1999) 0.78
Detergents affect insulin binding, tyrosine kinase activity and oligomeric structure of partially purified insulin receptors. Arch Biochem Biophys (1992) 0.78
[Implementing palliative care for newborns in various care settings. Part 3 of "Palliative care in the neonatal period"]. Arch Pediatr (2010) 0.78
[Premedication before tracheal intubation in French neonatal intensive care units and delivery rooms]. Arch Pediatr (2006) 0.78
[Chronic septic granulomatosis revealed by neonatal pulmonary aspergillosis]. Arch Pediatr (1995) 0.77
Two and one-half-year follow-up after isolated cadaveric small bowel transplantation in an infant. Transplant Proc (1992) 0.77
Physical alginate hydrogels based on hydrophobic or dual hydrophobic/ionic interactions: bead formation, structure, and stability. J Colloid Interface Sci (2004) 0.77
[Severe malaria in children in intensive care. National survey 1990-1995]. Arch Pediatr (2000) 0.77
Feasibility of surgery for patent ductus arteriosus of premature babies in a neonatal intensive care unit. Eur J Pediatr Surg (2003) 0.77
Incorporation of exogenous lipids modulates insulin signaling in the hepatoma cell line, HepG2. Biochim Biophys Acta (1999) 0.77
Rapid determination of 5-hydroxytryptamine in whole blood by liquid chromatography with fluorimetric detection. J Chromatogr (1991) 0.77
Metformin modulates insulin receptor signaling in normal and cholesterol-treated human hepatoma cells (HepG2). Eur J Pharmacol (1999) 0.77
Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Intensive Care Med (2001) 0.77